- ROUNDTABLE: Pharmacy’s future in sync with technology
- Study from NCPA sheds new light on med synchronization programs
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Senate passes Drug Quality and Security Act
- EXPERT BLOG: Provider status for pharmacists — one way or another
SAN DIEGO — HealthPrize Technologies and RealAge will launch a study next month that will test HealthPrize’s medication adherence technologies on patients taking asthma medications, the two companies said Wednesday.
HealthPrize is the creator of an Internet and mobile app that uses behavioral economics and gaming dynamics to improve medication adherence, while RealAge is a health website that uses the RealAge Test to assess a person’s mortality risk based on health-related factors.
The study will provide asthma patients who have taken the RealAge Test with access to HealthPrize’s adherence platform, where they can earn points for taking their medications, engage in health education and receive chances to win prizes.
“The medication adherence space presents a substantial opportunity for us and the 27 million people who have taken the RealAge Test,” RealAge president Gregg Zegras said. “We are uniquely positioned to motivate consumers to follow a prescribed health plan because people come to us when they are at the point of readiness to change their lifestyle behaviors.”